The global next generation contact lenses and visual prostheses market, valued at USD 0.36 billion in 2024, is projected to reach USD 0.60 billion in 2025 and USD 16.97 billion by 2035, representing a CAGR of 39.7% during the forecast period. It is worth highlighting here that there is a rapid increase witnessed in the number of blind and partially sighted individuals. According to the National Eye Institute, nearly 1.3 million people are blind, while 2.9 million individuals have poor vision, in...

The global AI-powered remote vital sign camera market is expected to rise from USD 2.2 billion in 2026 to reach USD 18.8 billion by 2040, growing at a CAGR of 16.6% over the forecast period 2026 to 2040, driven by telehealth adoption, software-only camera measurement, and contactless monitoring workflows. High-growth expansion will moderate after early adoption as reimbursement, privacy review and clinical validation shape procurement. Through 2040, edge AI health monitoring, multispectral sensi...

The global surgical robots market, valued at USD 9.8 billion in 2025, is projected to reach USD 10.6 billion in 2026 and USD 22.9 billion by 2035, with a 8.9% CAGR during the forecast period 2026 to 2035. In terms of geography, North America captures the majority of the market share.

The global CAR-T cell therapy market, valued at USD 6.1 billion in 2025, is projected to reach USD 7.7 billion in 2026 and USD 15.6 billion by 2035, with a 8.1% CAGR during the forecast period 2026 to 2035. In terms of target antigen, the CD19 targeting therapies segment holds the highest share (more than 65%) of the market. With regards to target indication, the multiple myeloma segment dominates the global market with close to 30% market share. In terms of geographical regions, North America c...

The global hospital at home market reached USD 29.0 billion in 2026 and is projected to reach USD 199.1 billion by 2040, growing at a CAGR of 14.8% over the forecast period 2026 to 2040, driven by hospital capacity constraints. Based on geography, North America captures 46.0% market share in 2026, whereas Asia-Pacific registers a 17.3% CAGR through 2040, driven by virtual hospital scale-up. Based on component / offering, Services capture 54.0% market share in 2026, whereas Software platforms reg...

The global neural implants market is expected to rise from USD 7.4 billion in 2026 to reach USD 29.2 billion by 2040, growing at a CAGR of 10.3% over the forecast period 2026 to 2040, driven by rising neurological disease burdens and adaptive closed-loop stimulation. Adaptive sensing and closed-loop stimulation are shifting neural implants from fixed-output devices toward responsive, personalized therapy. Spinal cord stimulation still anchors demand, holding 45.5% share in 2026, while deep brain...

The global Home Sleep Apnea Testing Market reached USD 1.90 billion in 2026 and is projected to reach USD 6.40 billion by 2040, growing at a CAGR of 9.1% over the forecast period 2026 to 2040, driven by untreated OSA prevalence, payer acceptance of HSAT, and AI-enabled multi-night diagnostics. Based on geography, North America captures 44.0% market share in 2026, whereas Asia-Pacific registers an 11.3% CAGR through 2040, driven by diagnostic-access gaps and local device innovation. Untreated obs...

The global contact lenses market, valued at USD 12.7 billion in 2025, is projected to reach USD 13.2 billion in 2026 and USD 20.5 billion by 2035, representing a CAGR of 5.0% during the forecast period 2026 to 2035. Contact lenses are thin, transparent optical devices placed directly on the cornea to correct refractive errors, and are currently worn by approximately 150 million individuals worldwide. In fact, in the US alone, an estimated 45 million people use contact lenses, with 87% opting fo...

The global mini bioreactors market, valued at USD 1.5 billion in 2025, is projected to reach USD 1.7 billion in 2026 and USD 4.0 billion by 2035, representing a CAGR of 10.4% during the forecast period 2026 to 2035. In terms of capacity of bioreactor, the 50 mL-250 mL segment holds the highest share of the current market. Based on the type of cell culture, the mammalian culture segment holds the largest share (close to 50%) of the current market.

The small scale bioreactors market is estimated to grow from USD 2,479 million in 2025 to reach USD 2,739 million in 2026 and USD 5,796 million by 2035, representing a CAGR of 8.68% during the forecast period 2026 to 2035. In 2025, the batch / fed batch mode of operation dominated the market and is estimated to hold 90% of the overall revenue share by 2035. Fed batch bioreactors provide controlled nutrient environment, preventing accumulation of inhibitory byproducts that can limit cell growth....

The global big data in healthcare market, valued at USD 93 billion in 2025, is projected to reach USD 110 billion in 2026 and USD 540 billion by 2035, with a 19.37% CAGR during the forecast period 2026 to 2035. The geographical regions segment highlights the distribution of big data in healthcare market across various geographies, such as North America, Europe, Asia, Latin America, Middle East and North Africa, and rest of the world regions. According to our projections, the big data analytic...

The global pediatric telehealth market is expected to rise from USD 58.0 billion in 2026 to reach USD 445.7 billion by 2040, growing at a CAGR of 15.7% over the forecast period 2026 to 2040, driven by rising child-focused virtual access, behavioral health demand and remote monitoring adoption. Based on Offering, Services capture 55.0% market share in 2026, whereas Software registers a 17.5% CAGR through 2040, driven by AI-enabled workflow expansion. Based on Delivery / Interaction Mode, Audiovis...

The ultrasound market is estimated to grow from USD 9.6 billion in 2025 to reach USD 10.2 billion in 2026 and USD 16.0 billion by 2035, representing a CAGR of 5.1% during the forecast period. In May 2026, ClearPoint Neuro entered into a collaboration with Sungkyunkwan University to expand its drug delivery ecosystem. The collaboration follows successful preclinical trials demonstrating ultrasound-enabled delivery across the blood-brain barrier, aiming to accelerate commercialization and global e...

The global Fc fusion protein market, valued at USD 40.7 billion in 2025, is projected to reach USD 45.0 billion in 2026 and USD 103.7 billion by 2035, representing a CAGR of 9.7% during the forecast period 2026 to 2035. In terms of type of fusion molecule, receptor ECD segment holds the highest share of the current market. In March 2026, Shanghai Henlius Biotech dosed the first patient in a Phase 1b/2 trial of HLX701, a next-generation SIRPα-Fc fusion protein, in combination with cetuximab and...

The global sexually transmitted disease (STD) testing market is expected to rise from USD 12.3 billion in 2026 to reach USD 33.0 billion by 2040, growing at a CAGR of 7.3% over the forecast period 2026 to 2040, driven by wider screening access and molecular-test adoption. Based on geography, North America captures 42.0% market share in 2026, whereas Asia-Pacific registers a 9.4% CAGR through 2040, supported by expanding screening infrastructure.

The global molecular glues market is expected to rise from USD 3.6 billion in 2026 and is projected to reach USD 17.8 billion by 2040, growing at a CAGR of 12.1% over the forecast period 2026 to 2040, driven by validated CRBN biology, broader E3 ligase recruitment, and AI-enabled degrader discovery. CRBN validation is shifting the molecular glues market from serendipitous discovery toward targeted protein degradation pipelines. Earlier activity centered on IKZF1 and IKZF3 biology, while current...

The global pulsed field ablation market, valued at USD 2.3 billion in 2025, is projected to reach USD 3.2 billion in 2026 and USD 14.6 billion by 2035, representing a CAGR of 18.4% during the forecast period 2026 to 2035. Clinical and preclinical research continues to expand the PFA evidence base, with multiple energy-delivery systems and procedural workflows under investigation. For instance, Boston Scientific’s FARAPULSE™ pulsed-field ablation (PFA) system demonstrated symptomatic relief i...

The E. coli fermentation market, valued at USD 7.8 billion in 2025, is projected to reach USD 8.6 billion in 2026 and USD 17.3 billion by 2035, representing a CAGR of 8.2% during the forecast period 2026 to 2035.Driven by the preference of major drug developers to retain end-to-end control over their proprietary microbial expression strains and quality control, the in-house manufacturers (~70%) dominate the E. coli fermentation market. In April 2026, WuXi Biologics achieved structural completion...

The global nanoparticle formulation market, valued at USD 6.2 billion in 2025, is projected to reach USD 6.8 billion in 2026 and USD 15.2 billion by 2035, with a CAGR of 9.3% during the forecast period 2026 to 2035. In June 2026, CEPI announced up to $9.7 million in additional funding to POP Biotechnologies to advance its SNAP nanoparticle-based vaccine platform into Phase 1 trials. The program targets rapid-response vaccines for epidemic threats such as H5N1 and Disease X, aiming to improve ant...

The global iPSC-derived cell therapy market is expected to rise from USD 1.52 billion in 2026 to reach USD 9.79 billion by 2040, growing at a CAGR of 14.2% over the forecast period 2026 to 2040, driven by clinical translation and scalable allogeneic platforms. Through 2040, the market will remain high-growth as gene-edited immune-evasive therapies gain share and reduce immunosuppression dependence. Pancreatic islet cells, cell engineering, and contract development services will outpace establish...